You are currently viewing a new version of our website. To view the old version click .
Children
  • Correction
  • Open Access

28 February 2025

Correction: Sánchez-Tena et al. Effectiveness of a Spectacle Lens with a Specific Asymmetric Myopic Peripheral Defocus: 12-Month Results in a Spanish Population. Children 2024, 11, 177

,
,
,
,
,
,
,
and
1
Department of Optometry and Vision, Faculty of Optics and Optometry, Universidad Complutense de Madrid, 28037 Madrid, Spain
2
ISEC LISBOA-Instituto Superior de Educação e Ciências, 1750-179 Lisbon, Portugal
3
Clinical Research Department, Indizen Optical Technologies, 28002 Madrid, Spain
4
Faculty of Biomedical and Health Science, Universidad Europea de Madrid, 28670 Madrid, Spain

Text Correction

There was an error in the original publication for the abstract [1]. In the abstract, the sentence was written as “After one year of treatment, there was less AL elongation in the study group compared to the control group (0.16 ± 0.16 mm vs. 0.24 ± 0.16 mm, p = 0.034)”, but the actual data for the manuscript should be “After one year, the AL increased by 0.14 ± 0.14 mm in the MPDL study group and by 0.23 ± 0.15 mm in the SVL control group (p = 0.014)”. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
The corrected abstract appears below:
  • Abstract: Background: Different designs of ophthalmic lenses have been studied to control the progression of myopia in children. This study aims to evaluate the short-term efficacy of a new design of ophthalmic lens with asymmetric myopic peripheral defocus (MPDL) on myopia progression in children compared to a control group wearing a single-vision lens (SVL). Methods: Children aged 5 to 12 with myopia up to −0.50 D, astigmatism and anisometropia under 1.50 D, and corrected visual acuity over 20/20 were randomized to either the study group (MPDL) or control group (SVL). The myopia progression was evaluated by measuring axial length (AL) growth (IOL Master; Zeiss) over a period of one year. Results: Ninety-two subjects were recruited. Forty-six children were randomly assigned to the control group, and 46 to the study group. In total, 83 children completed the clinical trial, with a mean age of 10.81 [9.53–11.92] years, among which 59.04% were female. After one year of treatment, there was less AL elongation in the study group compared to the control group (0.14 ± 0.14 mm vs. 0.23 ± 0.15 mm, p = 0.014). Conclusions: The MPDL significantly reduced the absolute growth of AL by 39% (p = 0.014) and relative growth of AL by 37.3% (p = 0.012) after 12 months in comparison to the control group in a Spanish population.

Reference

  1. Sánchez-Tena, M.Á.; Cleva, J.M.; Villa-Collar, C.; Álvarez, M.; Ruiz-Pomeda, A.; Martinez-Perez, C.; Andreu-Vazquez, C.; Chamorro, E.; Alvarez-Peregrina, C. Effectiveness of a Spectacle Lens with a Specific Asymmetric Myopic Peripheral Defocus: 12-Month Results in a Spanish Population. Children 2024, 11, 177. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.